Congress Moves to Require Licenses for Exporting Digital Synthetic DNA/RNA Designs to Foreign Entities of Concern
The Biological Intellectual Property Protection Act of 2025 passed a committee vote on April 21, 2026, but it is now considered stalled. The bill must still go through further committee consideration before it can move to the full House. A similar bill in the Senate has not made any progress.
Companion bill: Congress proposes export licenses for synthetic DNA/RNA sequence files to limit access by foreign entities of concern →No action since April 2026
Govbase has not yet run an impact analysis on this legislation.
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
The committee approved this bill and is sending it to the full chamber for a vote. This is a significant step — most bills never get this far.
Committee Consideration and Mark-up Session Held
Referred to the House Committee on Foreign Affairs.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Announces the Biological Intellectual Property Protection Act of 2025 and describes a proposed Commerce licensing requirement for exports/transfers of designed synthetic DNA/RNA sequences to foreign entities of concern, with research/publication carve-outs.
Roundup summarizing the bill’s stated purpose and core mechanism: a license requirement for exporting/transfer of synthetic DNA/RNA digital sequences to foreign entities of concern, plus exemptions tied to existing export rules.
Summarizes companion House legislation (H.R. 6624) creating a licensing requirement for exporting/transferring digital synthetic DNA/RNA sequences to foreign entities of concern, referencing exceptions under existing export regulations.
No votes recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Biological Intellectual Property Protection Act of 2025
Analysis generated by AI. Always verify with official sources.